Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
Leukemia|August 22, 2015
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working groupN M Kröger, J H Deeg, E Olavarria, et al.
Practical Radiation Oncology|September 5, 2024
Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR)Timothy A Ritter, Robert D Timmerman, Hena I Hanfi, et al.
Neuron|May 22, 2018
Astroglial CB<sub>1</sub> Receptors Determine Synaptic D-Serine Availability to Enable Recognition MemoryLaurie M Robin, José F Oliveira da Cruz, Valentin C Langlais, et al.
Bone Marrow Transplantation|April 29, 2021
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysisD McLornan, D J Eikema, T Czerw, et al.
Bone Marrow Transplantation|March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromesR Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation|November 22, 2023
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMTV Potter, L Gras, L Koster, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT ExperienceAbhishek A Solanki, Kevin Zheng, Alicia N Skipworth, et al.
Bone Marrow Transplantation|September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working partyC Scheid, L de Wreede, A van Biezen, et al.
Neuro-Oncology|February 25, 2022
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumorsGrayson A Herrgott, Karam P Asmaro, Michael Wells, et al.
ESMO Open|August 17, 2024
Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcomaA Dufresne, S Pokras, A Meurgey, et al.
Pageof 28